Literature DB >> 8545545

Functional characteristics of the midbrain periaqueductal gray.

M M Behbehani1.   

Abstract

The major functions of the midbrain periaqueductal gray (PAG), including pain and analgesia, fear and anxiety, vocalization, lordosis and cardiovascular control are considered in this review article. The PAG is an important site in ascending pain transmission. It receives afferents from nociceptive neurons in the spinal cord and sends projections to thalamic nuclei that process nociception. The PAG is also a major component of a descending pain inhibitory system. Activation of this system inhibits nociceptive neurons in the dorsal horn of the sinal cord. The dorsal PAG is a major site for processing of fear and anxiety. It interacts with the amygdala and its lesion alters fear and anxiety produced by stimulation of amygdala. Stimulation of PAG produces vocalization and its lesion produces mutism. The firing of many cells within the PAG correlates with vocalization. The PAG is a major site for lordosis and this role of PAG is mediated by a pathway connecting the medial preoptic with the PAG. The cardiovascular controlling network within the PAG are organized in columns. The dorsal column is involved in pressor and the ventrolateral column mediates depressor responses. The major intrinsic circuit within the PAG is a tonically-active GABAergic network and inhibition of this network is an important mechanism for activation of outputs of the PAG. The various functions of the PAG are interrelated and there is a significant interaction between different functional components of the PAG. Using the current information about the anatomy, physiology, and pharmacology of the PAG, a model is proposed to account for the interactions between these different functional components.

Entities:  

Mesh:

Year:  1995        PMID: 8545545     DOI: 10.1016/0301-0082(95)00009-k

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  201 in total

Review 1.  Neurogenic female sexual dysfunction: a review.

Authors:  M L Sipski; A Behnegar
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

2.  Periaqueductal gray matter modulates the hypercapnic ventilatory response.

Authors:  Luana T Lopes; Luis G A Patrone; Kênia C Bícego; Norberto C Coimbra; Luciane H Gargaglioni
Journal:  Pflugers Arch       Date:  2012-06-05       Impact factor: 3.657

3.  GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.

Authors:  Grace Lee; Stephen C Gammie
Journal:  Behav Brain Res       Date:  2010-05-08       Impact factor: 3.332

4.  Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain.

Authors:  Jianfei Guo; Xudong Fu; Xia Cui; Minhua Fan
Journal:  J Physiol Sci       Date:  2014-11-01       Impact factor: 2.781

5.  Tracheal occlusions evoke respiratory load compensation and neural activation in anesthetized rats.

Authors:  Kathryn M Pate; Paul W Davenport
Journal:  J Appl Physiol (1985)       Date:  2011-11-10

6.  Connections of the lateral hypothalamic area juxtadorsomedial region in the male rat.

Authors:  Joel D Hahn; Larry W Swanson
Journal:  J Comp Neurol       Date:  2012-06-15       Impact factor: 3.215

7.  Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway.

Authors:  Jihong Xing; Jian Kong; Jian Lu; Jianhua Li
Journal:  Neurosci Lett       Date:  2012-06-19       Impact factor: 3.046

Review 8.  Cerebral cortex modulation of pain.

Authors:  Yu-feng Xie; Fu-quan Huo; Jing-shi Tang
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

9.  Inactivation of the periaqueductal gray attenuates antinociception elicited by stimulation of the rat medial preoptic area.

Authors:  Yi-Hong Zhang; Matthew Ennis
Journal:  Neurosci Lett       Date:  2007-10-11       Impact factor: 3.046

Review 10.  Pain and analgesia: the value of salience circuits.

Authors:  David Borsook; Robert Edwards; Igor Elman; Lino Becerra; Jon Levine
Journal:  Prog Neurobiol       Date:  2013-03-07       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.